Validity and reliability of the greek version of the multiple sclerosis international quality-of-life questionnaire

Journal of Clinical Neurology (Korea)

Volumn 5, Issue 4, 2009, Pages 173-177

  Triantafyllou, Nikos ^a   Triantafillou, Aris ^b   Tsivgoulis, Georgios ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Epilepsy; Greece; Quality of life; Questionnaire

Indexed keywords

EID: 77954175390     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2009.5.4.173     Document Type: Article

References (24)

1. McCrone P, Heslin M, Knapp M, Bull P, Thompson A. Multiple sclerosis in the UK: service use, costs, quality of life and disability. Phar-macoeconomics 2008;26:847-860.
2. Miller DM, Kinkel RP. Health-related quality of life assessment in multiple sclerosis. Rev Neurol Dis 2008;5:56-64.
3. Motl RW, Snook EM. Physical activity, self-efficacy, and quality of life in multiple sclerosis. Ann Behav Med 2008;35:111-115.
4. Whalley D, McKenna SP. Measuring quality of life in patients with depression or anxiety. Pharmacoeconomics 1995;8:305-315.
5. Solari A. Role of health-related quality of life measures in the routine care of people with multiple sclerosis. Health Qual Life Outcomes 2005;3:16.
6. Simeoni M, Auquier P, Fernandez O, Flachenecker P, Stecchi S, Con-stantinescu C, et al. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler 2008;14:219-230.
7. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
8. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
9. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
10. Tsivgoulis G, Triantafyllou N, Papageorgiou C, Evangelopoulos ME, Kararizou E, Sfagos C, et al. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients. Acta Neurol Scand 2007;115:67-72.
11. Rentzos M, Cambouri C, Rombos A, Nikolaou C, Anagnostouli M, Tsoutsou A, et al. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci 2006;241:25-29.
12. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
13. Kurtzke JF. On the evaluation of disability in multiple sclerosis. Neurology 1961;11:686-694.
14. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, et al. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclo-phosphamide, plasma exchange, and ACTH. N Engl J Med 1983;308: 173-180.
15. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983;40:812.
16. Guy W. ECDEU Assessment manual for psychopharmacology, revised. Rockville, MD: U.S. Department of Health and Human Services, 1976;218-222.
17. Piperidou H, Terzoudi A, Vorvolakos T, Davis E, Heliopoulos I, Va-dikolias K, et al. The Greek version of the Quality of Life in Epilepsy Inventory (QOLIE-31). Qual Life Res 2006;15:833-839.
18. Piperidou C, Karlovasitou A, Triantafyllou N, Dimitrakoudi E, Ter-zoudi A, Mavraki E, et al. Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece. Qual Life Res 2008;17:987-996.
19. Courts NF, Buchanan EM, Werstlein PO. Focus groups: the lived experience of participants with multiple sclerosis. J Neurosci Nurs 2004; 36:42-47.
20. Somerset M, Peters TJ, Sharp DJ, Campbell R. Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Qual Life Res 2003;12:21-29.
21. Kaul P, Lytle BL, Spertus JA, DeLong ER, Peterson ED. Influence of racial disparities in procedure use on functional status outcomes among patients with coronary artery disease. Circulation 2005;111: 1284-1290.
22. Chavers LS, Gilbert GH, Shelton BJ. Racial and socioeconomic disparities in oral disadvantage, a measure of oral health-related quality of life: 24-month incidence. J Public Health Dent 2002;62:140-147.
23. Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G, et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996;47:129-139.
24. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995;4:187-206.